Gilead Sciences, Inc. Portfolio Stock Holdings
Gilead Sciences, Inc. disclosed 6 stock positions valued at approximately $2.1 billion in its latest SEC 13F filing. The largest holdings include Arcellx Inc, Arcus Biosciences Inc, and Galapagos NV. The filing reflects positions held as of March 31, 2026 and was filed on May 8, 2026.
- Report Period
- March 31, 2026
- No. of Stocks
- 6
- Portfolio Value
- $2.1B
Holdings by Sector
Gilead Sciences, Inc. Portfolio Holdings in Q1 2026
6 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| Arcellx Inc | ACLX | Healthcare | 36.44% | 6,720,803 | - | - | $771,682,600 |
| Arcus Biosciences Inc | RCUS | Healthcare | 32.05% | 31,424,760 | - | - | $678,774,816 |
| Galapagos NV | GLPG | Healthcare | 23.67% | 16,707,477 | - | - | $501,224,310 |
| Assembly Biosciences Inc | ASMB | Healthcare | 5.90% | 4,505,391 | - | - | $125,024,600 |
| Kyverna Therapeutics Inc | KYTX | Healthcare | 1.68% | 4,126,119 | - | - | $35,608,407 |
| Xilio Therapeutics Inc | XLO | Healthcare | 0.26% | 650,389 | -8,455,062 | -92.86% | $5,469,771 |